New Docs: NIH Owns Half of Moderna Vaccine
By Robert F. Kennedy, Jr., Chairman, Children’s Health Defense
New documents obtained by Axios and Public Citizen suggest that the National Institute of Health (NIH) owns half the key patent for Moderna’s controversial COVID vaccine and could collect half the royalties. In addition, four NIH scientists have filed their own provisional patent application as co-inventors. Little known NIH regulations let agency scientists collect up to $150,000.00 annually in royalties from vaccines upon which they worked. These rules are recipes for regulatory corruption.
NIH’s stake in the jab may explain why Anthony Fauci moved Moderna’s vaccine to the front of the line and to let Moderna skip animal trials despite the experimental technology and the inherent dangers of Coronavirus vaccines. Every prior coronavirus vaccine has proven problematic and can be lethal to animals due to COVID’s unique penchant for “pathogenic priming.” Death occurs only after a vaccinated animal encounters the wild virus.
Public health advocates and scientists criticized Fauci’s decision to skip animal trials as reckless. It may also explain why Anthony Fauci arranged a $483 million grant to Moderna from a sister NIH agency, BARDA, despite the fact that Moderna has never brought a product to market or gotten approval.